Silo Pharma (SILO) Notes Payables (2012 - 2022)

Silo Pharma (SILO) posted Notes Payables of $223645.0 for Q3 2022, up 43.43% sequentially from $155924.0 in Q2 2022.

Silo Pharma (SILO) Notes Payables (2012 - 2022) Analysis & Trends

Silo Pharma has reported Notes Payables for 6 years, with the latest figure at $223645.0 in Q3 2022.

Quarterly Notes Payables changed N/A year-over-year to $223645.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $223645.0 (changed N/A YoY) and the FY2021 annual result came in at $417937.0, up 2752.03% from the prior year.
Notes Payables rose to $223645.0 in Q3 2022 per SILO's latest filing, from $155924.0 in the prior quarter.
Over five years, Notes Payables peaked at $417937.0 in Q4 2021 and troughed at $2206.0 in Q1 2022.
A 4-year average of $97997.2 and a median of $25000.0 in 2019 frame the typical range for Notes Payables.
The widest YoY moves for Notes Payables: up 2752.03% in 2021, down 87.65% in 2021.
Over 4 years, Notes Payables stood at $61875.0 in 2019, then plunged by 76.32% to $14654.0 in 2020, then surged by 2752.03% to $417937.0 in 2021, then plunged by 46.49% to $223645.0 in 2022.
According to Business Quant data, Notes Payables over the past three periods registered $223645.0, $155924.0, and $2206.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	138.69 Bn	130.84 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.29 Bn	78.29 Bn	3.93 Bn
3	Argenx Se	64.79 Bn	59.60 Bn	1.37 Bn
4	Moderna	59.44 Bn	54.31 Bn	52.00 Mn
5	BeOne Medicines	42.07 Bn	36.97 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.92 Bn	27.61 Bn	992.69 Mn
7	BioNTech SE	28.10 Bn	9.71 Bn	668.28 Mn
8	Insmed	27.33 Bn	26.17 Bn	358.27 Mn
9	Royalty Pharma	27.00 Bn	26.17 Bn	-
10	Silo Pharma	3.06 Mn	3.06 Mn	-

Download Data